← Insider buys
ALRN

Aileron Therapeutics, Inc.

Novartis Bioventures Ltd sold $391K of Aileron Therapeutics, Inc.

10% owner

Sold$391,445
$2.06Price
190,338Shares
−8%Stake

What ALRN did after the filing

Prices for ALRN after this filing aren't in yet.

Traded Wed, Mar 13. Filed Fri, Mar 15, 1:25 PM ET, during the session. Not investment advice.